How is the Titan Pharmaceuticals, Inc. (de) today?

The Titan Pharmaceuticals, Inc. (de) today is trading in the down by -2.25% at 4.77.

What is Titan Pharmaceuticals, Inc. (de) Annual Net Profit?

Titan Pharmaceuticals, Inc. (de) Annual Net Profit rose 15.5% in the last year to $4.71 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is Titan Pharmaceuticals, Inc. (de) Price to Earning Ratio?

Titan Pharmaceuticals, Inc. (de) Price to Earning Ratio is -1.04, which is negative.

What is Titan Pharmaceuticals, Inc. (de) Stock Price?

Titan Pharmaceuticals, Inc. (de) Stock Price rose 9.4% outperformed its sector by 6.3% in the past week.

What is Titan Pharmaceuticals, Inc. (de) Quarterly Net profit?

Titan Pharmaceuticals, Inc. (de) Quarterly Net profit rose 46.89% YoY to $0.56 M. Its sector's average net profit growth YoY for the quarter was -238.37%.

What is Titan Pharmaceuticals, Inc. (de) Debt to Equity Ratio?

Titan Pharmaceuticals, Inc. (de) Debt to Equity Ratio is zero as the company is debt-free.

What is Titan Pharmaceuticals, Inc. (de) Return on Equity(ROE)?

Titan Pharmaceuticals, Inc. (de) Return on Equity(ROE) for the last financial year was -103.66%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Titan Pharmaceuticals, Inc. (de) Mutual Fund Holding?

Titan Pharmaceuticals, Inc. (de) Mutual Fund Holding increased by 0.15% in the last quarter to 2.03.

What is Titan Pharmaceuticals, Inc. (de) Promoter Share Holding?

Titan Pharmaceuticals, Inc. (de) Promoter Share Holding stayed the same in the most recent quarter at 0.08%.

What is Titan Pharmaceuticals, Inc. (de) Institutional Holding?

Titan Pharmaceuticals, Inc. (de) Institutional Holding decreased by 0.01% in the last quarter to 2.11.

Titan Pharmaceuticals, Inc. (de) XNAS: TTNP

Titan Pharmaceuticals, Inc. (de) Live Share Price Today, Share Analysis and Chart

Name: Titan Pharmaceuticals, Inc. (de): Is Infosys Ltd. worth buying?
Item: Titan Pharmaceuticals, Inc. (de)
Rating: 1.66441675
Author: Trendlyne DVM scores

about

Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treat...

4.77 -0.11 (-2.25%)

67.77% Fall from 52W High

403.6K XNAS Volume

High volume today

XNAS 03 Jun, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

8.7 / 100

Technically Neutral

57.9 / 100

No estimates available

Titan Pharmaceuticals, Inc... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Titan Pharmaceuticals, Inc. (de) FAQ

How is Titan Pharmaceuticals, Inc. (de) today?

Titan Pharmaceuticals, Inc. (de) today is trading in the red, and is down by -2.25% at 4.77.

How has Titan Pharmaceuticals, Inc. (de) performed historically?

Titan Pharmaceuticals, Inc. (de) is currently trading down -2.25% on an intraday basis. In the past week the stock rose 9.40%. stock has been up 19.85% in the past quarter and fell None% in the past year. You can view this in the overview section.